The Use of Benzodiazepines in Individuals with Bipolar Disorder: A Look at Recent Literature

References

• Aguglia, A., Natale, A., Fusar-Poli, L., Amerio, A., Bruno, E., Placenti, V., Vai, E., Costanza, A., Serafini, G., Aguglia, E., & Amore, M. (2022). Bipolar disorder and polysubstance use disorder: Sociodemographic and clinical correlates. Frontiers in Psychiatry, 13, 913965. https://doi.org/10.3389/fpsyt.2022.913965
   PubMed Web of Science ®Google Scholar
• Amore, M., D'Andrea, M., & Fagiolini, A. (2021). Treatment of agitation with lorazepam in clinical practice: A systematic review. Frontiers in Psychiatry, 12, 628965. https://doi.org/10.3389/fpsyt.2021.628965
   PubMed Web of Science ®Google Scholar
• Beunders, A. J. M., Kemp, T., Korten, N. C. M., Oudega, M. L., Beekman, A. T. F., Kupka, R. W., Stek, M. L., Schouws, S. N. T. M., & Dols, A. (2021). Cognitive performance in older-age bipolar disorder: Investigating psychiatric characteristics, cardiovascular burden and psychotropic medication. Acta Psychiatrica Scandinavica, 144(4), 392–406. https://doi.org/10.1111/acps.13342
   PubMed Web of Science ®Google Scholar
• Bo, Q., Mao, Z., Li, X., Wang, Z., Wang, C., & Ma, X. (2017). Use of the MATRICS consensus cognitive battery (MCCB) to evaluate cognitive deficits in bipolar disorder: A systematic review and meta-analysis. PLOS One, 12(4), e0176212. https://doi.org/10.1371/journal.pone.0176212
   PubMed Web of Science ®Google Scholar
• Cañada, Y., Sabater, A., Sierra, P., Balanzá-Martínez, V., Berk, M., Dodd, S., Navalón, P., García-Blanco, L., & A., Livianos. (2021). The effect of concomitant benzodiazepine use on neurocognition in stable, long-term patients with bipolar disorder. The Australian and New Zealand Journal of Psychiatry, 55(10), 1005–1016. https://doi.org/10.1177/0004867420969819
   PubMed Web of Science ®Google Scholar
• Caricasole, V., Di Bernardo, I., Varinelli, A., Galimberti, C., Zanello, R., Bosi, M., Ketter, T. A., Dell’Osso, C. A., & B., Viganò. (2019). Anxiety disorders anticipate the diagnosis of bipolar disorder in comorbid patients: Findings from an Italian tertiary clinic. Journal of Affective Disorders, 257, 376–381. https://doi.org/10.1016/j.jad.2019.07.033
   PubMed Web of Science ®Google Scholar
• Depp, C. A., Mausbach, B. T., Harmell, A. L., Savla, G. N., Bowie, C. R., Harvey, P. D., & Patterson, T. L. (2012). Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder. Bipolar Disorders, 14(3), 217–226. https://doi.org/10.1111/j.1399-5618.2012.01011.x
   PubMed Web of Science ®Google Scholar
• Elias, L. R., Miskowiak, K. W., Vale, A. M., Köhler, C. A., Kjærstad, H. L., Stubbs, B., Kessing, L. V., Vieta, E., Maes, M., Goldstein, B. I., & Carvalho, A. F. (2017). Cognitive impairment in euthymic pediatric bipolar disorder: A systematic review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 56(4), 286–296. https://doi.org/10.1016/j.jaac.2017.01.008
   PubMed Web of Science ®Google Scholar
• Inoue, T., Sano, H., Kojima, Y., Yamada, S., & Shirakawa, O. (2021). Real-world treatment patterns and adherence to oral medication among patients with bipolar disorders: A retrospective, observational study using a healthcare claims database. Neuropsychiatric Disease and Treatment, 17, 821–833. https://doi.org/10.2147/NDT.S299005
   PubMed Web of Science ®Google Scholar
• Jain, R., Kong, A. M., Gillard, P., & Harrington, A. (2022). Treatment patterns among patients with bipolar disorder in the United States: A retrospective claims database analysis. Advances in Therapy, 39(6), 2578–2595. https://doi.org/10.1007/s12325-022-02112-6
   PubMed Web of Science ®Google Scholar
• Jing, P., Su, J., Zheng, C., Mei, X., & Zhang, X. (2023). A retrospective study of psychotropic drug treatments in bipolar disorder at acute and maintenance episodes. Frontiers in Psychiatry, 14, 1057780. https://doi.org/10.3389/fpsyt.2023.1057780
   PubMed Web of Science ®Google Scholar
• Kousgaard, S. J., Licht, R. W., & Nielsen, R. E. (2017). Effects of intramuscular midazolam and lorazepam on acute agitation in non-elderly subjects – A systematic review. Pharmacopsychiatry, 50(4), 129–135. https://doi.org/10.1055/s-0043-100766
   PubMed Web of Science ®Google Scholar
• Lappas, A. S., Helfer, B., Henke-Ciążyńska, K., Samara, M. T., & Christodoulou, N. (2023). Antimanic efficacy, tolerability, and acceptability of clonazepam: A systematic review and meta-analysis. Journal of Clinical Medicine, 12(18), 5801. https://doi.org/10.3390/jcm12185801
   PubMed Web of Science ®Google Scholar
• Messer, T., Lammers, G., Müller-Siecheneder, F., Schmidt, R. F., & Latifi, S. (2017). Substance abuse in patients with bipolar disorder: A systematic review and meta-analysis. Psychiatry Research, 253, 338–350. https://doi.org/10.1016/j.psychres.2017.02.067
   PubMed Web of Science ®Google Scholar
• Montejo, L., Torrent, C., Jiménez, E., Martínez-Arán, A., Blumberg, H. P., Burdick, K. E., Chen, P., Dols, A., Eyler, L. T., Forester, B. P., Gatchel, J. R., Gildengers, A., Kessing, L. V., Miskowiak, K. W., Olagunju, A. T., Patrick, R. E., Schouws, S., Radua, J., Bonnín, C. D. M., … Vieta, E. (2022). Cognition in older adults with bipolar disorder: An ISBD task force systematic review and meta-analysis based on a comprehensive neuropsychological assessment. Bipolar Disorders, 24(2), 115–136. https://doi.org/10.1111/bdi.13175
   PubMed Web of Science ®Google Scholar
• Nabavi, B., Mitchell, A. J., & Nutt, D. (2015). A lifetime prevalence of comorbidity between bipolar affective disorder and anxiety disorders: A meta-analysis of 52 interview-based studies of psychiatric population. EBioMedicine, 2(10), 1405–1419. https://doi.org/10.1016/j.ebiom.2015.09.006
   PubMed Web of Science ®Google Scholar
• Pacchiarotti, I., Anmella, G., Colomer, L., & Vieta, E. (2020). How to treat mania. Acta Psychiatrica Scandinavica, 142(3), 173–192. https://doi.org/10.1111/acps.13209
   PubMed Web of Science ®Google Scholar
• Perlis, R. H., Ostacher, M. J., Miklowitz, D. J., Smoller, J. W., Dennehy, E. B., Cowperthwait, C., Thase, A. A., Sachs, M. E., & G. S., Nierenberg. (2010). Benzodiazepine use and risk of recurrence in bipolar disorder: A STEP-BD report. The Journal of Clinical Psychiatry, 71(2), 194–200. https://doi.org/10.4088/JCP.09m05019yel
   PubMed Web of Science ®Google Scholar
• Poranen, J., Koistinaho, A., Tanskanen, A., Tiihonen, J., Taipale, H., & Lähteenvuo, M. (2022). Twenty-year medication use trends in first-episode bipolar disorder. Acta Psychiatrica Scandinavica, 146(6), 583–593. https://doi.org/10.1111/acps.13504
   PubMed Web of Science ®Google Scholar
• Saha, S., Lim, C. C., Degenhardt, L., Cannon, D. L., Bremner, M., Prentis, F., Lawrence, Z., Meurk, E., Reilly, C., McGrath, J., & J. J., Heffernan. (2022). Comorbidity between mood and substance-related disorders: A systematic review and meta-analysis. The Australian and New Zealand Journal of Psychiatry, 56(7), 757–770. https://doi.org/10.1177/00048674211054740
   PubMed Web of Science ®Google Scholar
• Tondo, L., Miola, A., Pinna, M., Contu, M., & Baldessarini, R. J. (2022). Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept. International Journal of Bipolar Disorders, 10(1), 21. https://doi.org/10.1186/s40345-022-00268-2
   PubMed Web of Science ®Google Scholar
• Ward, K., & Citrome, L. (2020). The treatment of acute agitation associated with schizophrenia or bipolar disorder: Investigational drugs in early stages of their clinical development, and their clinical context and potential place in therapy. Expert Opinion on Investigational Drugs, 29(3), 245–257. https://doi.org/10.1080/13543784.2020.1727884
   PubMed Web of Science ®Google Scholar
• Wingård, L., Taipale, H., Reutfors, J., Westerlund, A., Bodén, R., Tiihonen, J., Tanskanen, A., & Andersen, M. (2018). Initiation and long-term use of benzodiazepines and Z-drugs in bipolar disorder. Bipolar Disorders, 20(7), 634–646. https://doi.org/10.1111/bdi.12626
   PubMed Web of Science ®Google Scholar
• Zaman, H., Sampson, S., Beck, A., Sharma, T., Clay, F., Spyridi, S., Zhao, S., & Gillies, D. (2018). Benzodiazepines for psychosis-induced aggression or agitation. Schizophrenia Bulletin, 44(5), 966–969. https://doi.org/10.1093/schbul/sby056
   PubMed Web of Science ®Google Scholar